Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals.
Clinical Benefit
| Moderate |
Le service médical rendu par DICLOFENAC MIKA PHARMA 4% est modéré.
|
Clinical Added Value
| no clinical added value |
La spécialité Diclofénac Mika Pharma 4% n’apporte pas d’amélioration du service médical rendu (ASMR V) par rapport aux autres AINS topiques.
|
eNq9mF1v2jAUhu/5FVHukxQGpZ0C1cbaDanVGAVt2k11SE6KqbFTfwDdr59DqAZToq6mnrjCdt5z4vP68VHii82SeisUknDW85vhie8hS3hK2H3Pn06ugjP/ot+IF7CCvWXd8CRstnwvoSBlzy9mwxkCk+GPm+tPaJ5H4fcbXsxnC0zUwTqtCA2/gJzfQF6s8eIVJ6m3RDXnac/PtdqOerFUwmTRX3PxIHNIMI52I/uzi7v2/ngcFWL/oKolimtg95WiyKw0Ey0EMjUAhfdcPNXk+85Km8gxSq5FgiNQ85HgK5JiWhkiAyrRKki2Tm9RrCiqIkileLRIltJKHBawGePjsDrpD2Z2oDYqOAma3U6702o1T4ufVSixt1XVVTAvESV37W633TqPkEUpSSjPkEESSGP+R43BkjxAkM9BLMGyYiMuFFBHtSJycGg3R3EEPr7oiZTInMJTuJC57VaBADONwkDB3YsUbzARBlPU7Nlf+kxTGr0y6+kOIo4yLhg14JqpGpZcjW03YsCZwk19Re3wpzY7LxKUbyf7i7Nq9I/0jJLEFnQGRRqlmo6H9Zxzj4iPIHEq3DHiO2EpX8u3Z89+rR1ln2/xWSmai7R51zo/O212OtZH66cxVs1tdKkFzzEyVCLyGNgMWcaPxYzxarXUs1Mdm3TbKfEEKNb0SoElh4w7n1s7Z/53d7bKiUrRz5cTW9N80yiebrd/K6VJ2nsutx2jXYDfOLQ279f7vTz2TppoLapxMlcql++jaL1eh3OQgQSzS2Em/tMlsHcbu2vsnVz5ZQtUgtRR6rPyhnxd3WyP30tNwbGN7u75XUNdGUMJjUfUoiS1M54OL98e0X+6XGdpjw6Y4i7MtiMFRThz1RPpWaXiUZeCKSu7EoYPX7OM1HxnqbVlHJXfePqNOCq+7/QbvwFWYwaK
drbSqm8s6ctBFen6
Listen
